Christopher Mark Edwards
Secretario Corporativo en Wright & Offland Holdings Ltd. .
Perfil
Christopher Mark Edwards is the founder of Pulmagen Therapeutics (Synergy) Ltd., which was founded in 2000.
He is currently working as a Secretary at Wright & Offland Holdings Ltd.
Cargos activos de Christopher Mark Edwards
| Empresas | Cargo | Inicio |
|---|---|---|
Wright & Offland Holdings Ltd.
 Wright & Offland Holdings Ltd. Home FurnishingsConsumer Durables Wright & Offland Holdings Ltd. manufactures and wholesales glass and glass products. The company was established in 1988 and is headquartered in Manchester, GB | Secretario Corporativo | 01/06/2006 |
Antiguos cargos conocidos de Christopher Mark Edwards.
| Empresas | Cargo | Fin |
|---|---|---|
Pulmagen Therapeutics (Synergy) Ltd.
 Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Wright & Offland Holdings Ltd.
Wright & Offland Holdings Ltd. Home FurnishingsConsumer Durables Wright & Offland Holdings Ltd. manufactures and wholesales glass and glass products. The company was established in 1988 and is headquartered in Manchester, GB | Consumer Durables |
Pulmagen Therapeutics (Synergy) Ltd.
Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Commercial Services |
- Bolsa de valores
- Insiders
- Christopher Mark Edwards
